Integral Diagnostics Limited (ASX:IDX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Integral Diagnostics' estimated fair value is AU$4.08 based on 2 Stage Free Cash Flow to Equity
Integral Diagnostics' AU$2.27 share price signals that it might be 44% undervalued
Our fair value estimate is 29% higher than Integral Diagnostics' analyst price target of AU$3.15
Today we will run through one way of estimating the intrinsic value of Integral Diagnostics Limited (ASX:IDX) by projecting its future cash flows and then discounting them to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
Our free stock report includes 3 warning signs investors should be aware of before investing in Integral Diagnostics. Read for free now.
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
Levered FCF (A$, Millions)
AU$20.0m
AU$54.8m
AU$59.8m
AU$61.0m
AU$64.0m
AU$66.5m
AU$68.9m
AU$71.2m
AU$73.4m
AU$75.6m
Growth Rate Estimate Source
Analyst x4
Analyst x6
Analyst x6
Analyst x2
Analyst x2
Est @ 3.92%
Est @ 3.56%
Est @ 3.32%
Est @ 3.14%
Est @ 3.02%
Present Value (A$, Millions) Discounted @ 6.5%
AU$18.8
AU$48.3
AU$49.5
AU$47.4
AU$46.7
AU$45.5
AU$44.3
AU$42.9
AU$41.6
AU$40.2
("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = AU$425m
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.7%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 6.5%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = AU$76m× (1 + 2.7%) ÷ (6.5%– 2.7%) = AU$2.1b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= AU$2.1b÷ ( 1 + 6.5%)10= AU$1.1b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is AU$1.5b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of AU$2.3, the company appears quite good value at a 44% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Integral Diagnostics as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.5%, which is based on a levered beta of 0.874. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
View our latest analysis for Integral Diagnostics
Strength
Debt is well covered by cash flow.
Weakness
Interest payments on debt are not well covered.
Dividend is low compared to the top 25% of dividend payers in the Healthcare market.
Shareholders have been diluted in the past year.
Opportunity
Annual earnings are forecast to grow faster than the Australian market.
Trading below our estimate of fair value by more than 20%.
Significant insider buying over the past 3 months.
Threat
Dividends are not covered by earnings.
Revenue is forecast to grow slower than 20% per year.
Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. What is the reason for the share price sitting below the intrinsic value? For Integral Diagnostics, there are three additional elements you should assess:
Risks: Be aware that Integral Diagnostics is showing 3 warning signs in our investment analysis , and 2 of those are a bit concerning...
Future Earnings: How does IDX's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the ASX every day. If you want to find the calculation for other stocks just search here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
Dell Technologies (NYSE:DELL) Appoints Manish Gupta To Lead India Operations
Dell Technologies recently announced the appointment of Manish Gupta as the new President and Managing Director for its India operations. Over the last quarter, Dell's stock price surged 24%, largely aligned with favorable market conditions, which saw a 13% rise over the past year. The increase could be supported by Dell's strong earnings guidance and strategic partnerships, such as collaborations in AI solutions with Accenture and NVIDIA. Additionally, the company's AI infrastructure advancements and share buybacks might have bolstered investor confidence, reinforcing the broader market trend during this period. We've identified 3 warning signs for Dell Technologies that you should be aware of. This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. The recent appointment of Manish Gupta as Dell's new President for India is poised to further align the company with its AI and collaboration objectives, potentially enhancing revenue streams and strengthening its market presence. Dell's strong emphasis on AI and infrastructure solutions, coupled with strategic partnerships, could bolster revenue growth and earnings forecasts, contingent on successful execution and market conditions. Over the past five years, Dell's total shareholder return, including share price appreciation and dividends, was substantially high at 419.02%. In contrast, over the past year, Dell's shares underperformed compared to the US Tech industry, which had a 2.5% increase, while Dell experienced a 24% surge over the last quarter. This underperformance may reflect broader market pressures and industry challenges amidst growth expectations. The strong share price movement, while positive, positions Dell's current share price ($93.95) below the analysts' consensus price target of $125.98, indicating a potential gap of 25.4%. This suggests that investors see promise in Dell's future prospects, including AI advancements and growth strategies. Yet, as the company navigates competitive pricing and demand fluctuations, the impact on revenue, earnings forecasts, and valuation metrics will be pivotal for long-term success. Dive into the specifics of Dell Technologies here with our thorough balance sheet health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:DELL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
19 hours ago
- Yahoo
Church & Dwight (NYSE:CHD) Recalls Zicam and Orajel Products Over Microbial Contamination Concerns
Church & Dwight recently announced a voluntary recall of several products, including Zicam Cold Remedy Nasal Swabs and Orajel Baby Teething Swabs, due to potential fungal contamination risk, notably posing health threats to children and people with compromised immune systems. While no adverse events have been reported, this recall coincided with a 7.7% rise in the company's stock over the last month, reflecting broader market movements. The broader market rose by 1.8% over the past seven days and 13% over the last year, suggesting the recall might have temporarily added counterweight against the positive market trend. We've discovered 1 weakness for Church & Dwight that you should be aware of before investing here. Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. The voluntary recall of Church & Dwight's products, such as Zicam Cold Remedy Nasal Swabs, highlights challenges the company may face in its efforts to optimize its brand portfolio and stabilize earnings. This event, coupled with the company's rise in share price, mirrors broader market trends despite the recall's potential temporary impact. Over the past five years, the company's total shareholder return, including both share price growth and dividends, was 43.63%, showing a commendable performance in a challenging market environment. For context, during the past year, Church & Dwight's performance lagged behind not only the US Household Products industry, which experienced a 3.8% decline, but also the wider US market, which climbed 11%. Looking ahead, potential impacts on revenue and earnings forecasts from the recall include the continuation of U.S. sales declines or a slower recovery in earnings growth projections. Analysts anticipate a 2.7% annual revenue growth over the next three years, potentially hindered by ongoing consumer demand issues and macroeconomic pressures. Despite the recent share price movement and recall news, the company's current share price of US$92.07 trades at a small discount to analysts' consensus price target of US$99.6. This indicates expectations of moderate upside potential. Prospective investors might weigh these dynamics against the ongoing brand optimization and potential tariff impacts as Church & Dwight seeks to enhance its market position and financial health. Understand Church & Dwight's track record by examining our performance history report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CHD. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
19 hours ago
- Yahoo
TELUS (TSX:T) Collaborates With Edmonton Police For Pioneering 5G Public Safety Initiative
TELUS recently achieved a significant milestone with the deployment of 5G priority slice technology in Edmonton, enhancing public safety during high-profile events. This development, conducted in collaboration with the Edmonton Police Service, underscores the company's innovative advancements in technology. Over the past month, TELUS's share price rose by 8%, noticeably higher than the market's 1.8% gain in the same period. This upward movement was supported by recent major investments and advancements, such as the commitment to expand its network infrastructure across Canada, further aligning with the broader positive market trends. We've identified 2 weaknesses with TELUS and understanding the impact should be part of your investment process. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. The recent deployment of 5G priority slice technology in Edmonton could further strengthen TELUS's position in the telecom sector. This innovation not only enhances public safety but also demonstrates TELUS's commitment to adopting advanced technologies that could potentially drive revenue and earnings growth. As TELUS expands its network infrastructure, it aligns with the projected revenue and earnings growth forecasts, which analysts expect to rise by 3.2% annually over the next three years. Over the past five years, TELUS achieved a total return of 24.24%, which implies a consistent return for shareholders, highlighting the company's stability in the industry. However, over the last year, TELUS underperformed compared to the Canadian Market, which returned 16.9%. This reflects challenges in maintaining competitive performance amidst industry pressures. The recent share price increase of 8% supports analyst forecasts regarding TELUS's future growth, although it suggests a relatively modest gap to the CA$22.78 consensus price target. With the current share price at CA$20.99, TELUS's stock is priced close to analyst expectations, indicating a belief that the company is fairly valued based on anticipated earnings growth and profitability improvements. The ongoing implementation of cutting-edge technology and network expansion initiatives could potentially boost TELUS's competitive edge and support its longer-term growth narrative. Evaluate TELUS' historical performance by accessing our past performance report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:T. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
